Inspiremd announces inducement grants under nasdaq listing rule 5635(c)(4)

Miami, nov. 08, 2024 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ prime carotid stent system for the prevention of stroke, today announced that the compensation committee of inspiremd's board of directors approved inducement grants to five new non-executive employees in the aggregate amount of 197,167 shares of restricted stock outside of inspiremd's 2021 equity compensation plan, with a grant date as of october 24, 2024, as an inducement material to the employee entering into employment with inspiremd, in accordance with nasdaq listing rule 5635(c)(4).
NSPR Ratings Summary
NSPR Quant Ranking